Trial Information
Quantifying Needle Deflection and Tissue Deformation in Transperineal Interstitial Permanent Prostate Brachytherapy: A Basis for Development of Next-Generation Implant Technique
Inclusion Criteria:
- Prostate cancer
- Treated with prostate brachytherapy at the Cross Cancer Institute
- Low and intermediate risk prostate cancer
- ambulatory patients
- stable medical condition
- Over 18 years of age
- Capable of giving informed consent
Exclusion Criteria:
- Any hormonal therapy
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Principal Investigator
Nawaid Usmani, MD, FRCPC
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Alberta
Authority:
Canada: Health Canada
Study ID:
25837
NCT ID:
NCT01437085
Start Date:
October 2011
Completion Date:
January 2013
Related Keywords:
- Prostate Cancer
- Needle deflection
- Prostate Deformation
- Prostate Brachytherapy
- Needles
- Prostatic Neoplasms